Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pelmear PL, Roos JO, Maehle WM: Occupationally-induced scleroderma. J Occup Med 1992, 34: 20–25.
Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W: Scleroderma and occupational exposure. Scand J Work Environ Health 1995, 21: 289–292.
Kütting B, Otto A, Drexler H: Systemische Sklerodermie bei beruflicher Exposition zu Lösemitteln – eine neue Berufskrankheit? [Systemic sclerosis and work-related exposure to solvents – a new occupational disease]. Dermatologie in Beruf und Umwelt 2004, 52: 1–8.
Cook NJ, Silman AJ, Propert J, Cawley MID: Features of systemic sclerosis in an identical twin pair. Br J Rheumatol 1993, 32: 926–928.
Faghali CA, Wright TM: epidemiological and clinical studies of twins with scleroderma. Arthritis Rheum 1995, 38: S308.
Silman AJ, Hochberg MC: Occupational and environmental influences on scleroderma. Rheum Dis Clin North Am 1996, 4: 737–747. 10.1016/S0889-857X(05)70298-2
Maddison PJ, Skinner RP, Pereira RS, Black CM, Ansell BM, Jayson MI, Rowel NR, Welsh KI: Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis 1986, 45: 793–799.
McNeilage LJ, Youngchaiyud U, Whittigham S: Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989, 32: 54–60.
Beebe JL, Lacey JB, Mayes MD, Gillespie BW, Cooper BC, Laing TJ, Schottenfeld D: Reproductive history, oral contraceptive use, oestrogen replacement therapy and the risk of developing of scleroderma. Arthritis Rheum 1997, 40: S100.
D'Cruz D: Autoimmune disease associated with drugs, chemicals and environmental factors. Toxicolology Letters 2000, 112–123: 421–432. 10.1016/S0378-4274(99)00220-9
Reinl W: Scleroderma caused by trichloroethylene in workers. Bull Hyg 1957, 32: 678.
Bottomley WW, Sheehan-Dare RA, Hughes P, Cunliffe WJ: A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol 1993, 128: 203–206.
Czirják L, Schlammadinger J, Szegedi G: Systemic sclerosis and exposure to trichloroethylene. Dermatology 1993, 186: 236.
Czirják L, Pócs E, Szegedi G: Localized scleroderma after exposure to organic solvents. Dermatology 1994, 189: 399–401.
Flindt-Hansen H, Isager H: Scleroderma after occupational exposure to trichlorethylene and Trichlorethane. Acta Derm Venereol [Stockh] 1987, 67: 263–264.
Waldner BK: Do solvents cause scleroderma? Int J Dermatol 1983,22(3):157–158.
Yamakage A, Ishikawa H: Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica 1982, 165: 186–193.
Aryal BK, Khuder SA, Schaub EA: Meta-Analysis of Systemic Sclerosis and exposure to solvents. Am J Ind Med 2001, 40: 271–274. 10.1002/ajim.1098
Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, Stadler M, Diot P, Lemarie E, Lasfargues G: Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002,59(8):545–549. 10.1136/oem.59.8.545
Garabrant DH, Lacey JV, Laing TJ, Gillespie BW, Mayes MD, Cooper BC, Schottenfeld D: Scleroderma and solvent exposure among women. Am J Epidemiol 2003, 157: 493–500. 10.1093/aje/kwf223
Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, Biasi D, Caramaschi P: A case control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health 2004, 77: 10–16. 10.1007/s00420-003-0462-5
Silman AJ, Jones S: What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992, 51: 1322–1324.
Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M: Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998, 41: 1111–1118. 10.1002/1529-0131(199806)41:6<1111::AID-ART19>3.0.CO;2-J